Recently, Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a game-changer in this field, demonstrating remarkable efficacy in promoting significant and long-term weight loss
In fact, growth hormone releasing peptides were discovered several years prior, starting with GHRP-6 and GHRP-2, as scientists were particularly interested in their benefits for heart health [14]
Yu et al., 2019)
Stracke, H., Lindemann, A
The clinic publishes four indicative benefit figures for KPV: 94 percent for anti inflammatory support, 90 percent for gut healing support, 88 percent for immune regulation and 85 percent for skin and tissue recovery